Endarachne binghamiae Ameliorates Hepatic Steatosis, Obesity, and Blood Glucose via Modulation of Metabolic Pathways and Oxidative Stress
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sang-Seop Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, College of Medicine, Konyang University, Daejon 32992, Republic of Korea. Hauptthemen laut MEDLINE: Obesity, Oxidative Stress, Blood Glucose, Metabolic Networks and Pathways. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Forestry Promotion Institute, Bio & Medical Technology Development Program of the National Research Foundation (NRF).
Abstract (Originalsprache)
Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are major contributors to the rise in metabolic disorders, particularly in developed countries. Despite the need for effective therapies, natural product-based interventions remain underexplored. This study investigated the therapeutic effects of Endarachne binghamiae, a type of brown algae, hot water extract (EB-WE) in ameliorating obesity and MASLD using high-fat diet (HFD)-induced ICR mice for an acute obesity model (4-week HFD feeding) and C57BL/6 mice for a long-term MASLD model (12-week HFD feeding). EB-WE administration significantly reduced body and organ weights and improved serum lipid markers, such as triglycerides (TG), total cholesterol (T-CHO), HDL (high-density lipoprotein), LDL (low-density lipoprotein), adiponectin, and apolipoprotein A1 (ApoA1). mRNA expression analysis of liver and skeletal muscle tissues revealed that EB-WE upregulated Ampkα and Cpt1 while downregulating Cebpα and Srebp1, suppressing lipogenic signaling. Additionally, EB-WE activated brown adipose tissue through Pgc1α and Ucp1, contributing to fatty liver alleviation. Western blot analysis of liver tissues demonstrated that EB-WE enhanced AMPK phosphorylation and modulated lipid metabolism by upregulating PGC-1α and UCP-1 and downregulating PPAR-γ, C/EBP-α, and FABP4 proteins. It also reduced oxidation markers, such as OxLDL (oxidized low-density lipoprotein) and ApoB (apolipoprotein B), while increasing ApoA1 levels. EB-WE suppressed lipid peroxidation by modulating oxidative stress markers, such as SOD (superoxide dismutase), CAT (catalase), GSH (glutathione), and MDA (malondialdehyde), in liver tissues. Furthermore, EB-WE regulated the glucose regulatory pathway in the liver and muscle by inhibiting the expression of Sirt1, Sirt4, Glut2, and Glut4 while increasing the expression of Nrf2 and Ho1. Tentative liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis for EB-WE identified bioactive compounds, such as pyropheophorbide A and digiprolactone, which are known to have antioxidant or metabolic regulatory activities. These findings suggest that EB-WE improves obesity and MASLD through regulation of metabolic pathways, glucose homeostasis, and antioxidant activity, making it a promising candidate for natural product-based functional foods and pharmaceuticals targeting metabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, College of Medicine, Konyang University, Daejon 32992, Republic of Korea.
- Department of Anatomy, College of Medicine, Konyang University, Daejon 32992, Republic of Korea.
- Department of Chemical and Biological Engineering, College of Engineering, Hanbat National University, Daejon 34158, Republic of Korea.
- CINNAM Ltd., Daejon 34158, Republic of Korea.
ORCID-Profile: Sang-Seop Lee, Sang-Hoon Lee, Seung-Yun Han
Förderung
- National Research Foundation of Korea
- Korea Forestry Promotion Institute
- Bio & Medical Technology Development Program of the National Research Foundation (NRF)
- R&D Program for Forest Science Technology
Zitieren
APA
Lee, S. S., Lee, S. H., Kim, S. Y., Lee, G. Y., Han, S. Y., Lee, B. H., & Yoo, Y. C. (2025). Endarachne binghamiae Ameliorates Hepatic Steatosis, Obesity, and Blood Glucose via Modulation of Metabolic Pathways and Oxidative Stress. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115103
Vancouver
Lee SS, Lee SH, Kim SY, Lee GY, Han SY, Lee BH, et al. Endarachne binghamiae Ameliorates Hepatic Steatosis, Obesity, and Blood Glucose via Modulation of Metabolic Pathways and Oxidative Stress. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115103
BibTeX
@article{Lee2025,
author = {Lee, Sang-Seop and Lee, Sang-Hoon and Kim, So-Yeon and Lee, Ga-Young and Han, Seung-Yun and Lee, Bong-Ho and Yoo, Yung-Choon},
title = {Endarachne binghamiae Ameliorates Hepatic Steatosis, Obesity, and Blood Glucose via Modulation of Metabolic Pathways and Oxidative Stress},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115103}
}
EUVIMED